What is the address of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE?

The registered office of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is located at Langeboeken 3, 9930 Lievegem.

Is DR. KRISTEL VANCHAZE, NEUROCHIRURGIE still active?

Yes. According to the CBE (18 September 2026) DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is active, legal situation “Normale toestand”, started on 10 November 2020.

Is DR. KRISTEL VANCHAZE, NEUROCHIRURGIE registered on Peppol?

Yes, DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is registered on the Peppol network with ID 0208:0757945231.

What is the enterprise number of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE?

The enterprise number of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is BE0757945231.

When was DR. KRISTEL VANCHAZE, NEUROCHIRURGIE founded?

DR. KRISTEL VANCHAZE, NEUROCHIRURGIE was founded on 10 November 2020.

Who are the directors of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE?

According to the 2025 annual accounts, the directors of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE are: Kristel Vanchaze.

Is DR. KRISTEL VANCHAZE, NEUROCHIRURGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 November 2020; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KRISTEL VANCHAZE, NEUROCHIRURGIE make in 2025?

DR. KRISTEL VANCHAZE, NEUROCHIRURGIE posted a profit after taxes of € 138,135 in financial year 2025.

What is the revenue of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE?

As a small company, DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 220,276.

DR. KRISTEL VANCHAZE, NEUROCHIRURGIE (Private Limited)

Dossier DR. KRISTEL VANCHAZE, NEUROCHIRURGIE, printed on 18 September 2026 from databakkes.be/en/0757945231/dr-kristel-vanchaze-neurochirurgie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KRISTEL VANCHAZE, NEUROCHIRURGIE from Lievegem, company number BE0757945231, closed financial year 2025 with a result of € 138,135 after tax. For that financial year DR. KRISTEL VANCHAZE, NEUROCHIRURGIE recorded a gross margin of € 220,276 and equity of € 148,713. Compared with financial year 2024, the result moved from € 129,898 to € 138,135. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 9, 2026.

What it is worth Growing

€ 148,713

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 138,135

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 113,433

▲ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

87 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 18,077

▼ 51% vs 2024

Of which on lease € 5,813.

Debts at end 2025

Bank debt

€ 7,430

▼ 63% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,589

▲ 65% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,445

▼ 61% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 157,944 Gross margin 2022: € 157,944 First fiscal year in the series	€ 113,444 Gross margin 2023: € 113,444 ▼ 28% vs 2022 (€ 157,944) Unfavourable step	€ 194,699 Gross margin 2024: € 194,699 ▲ 72% vs 2023 (€ 113,444) Favourable step	€ 220,276 Gross margin 2025: € 220,276 ▲ 13% vs 2024 (€ 194,699) Favourable step	▲ 13%
Profit after taxes	€ 109,680 Profit after taxes 2022: € 109,680 First fiscal year in the series	€ 73,499 Profit after taxes 2023: € 73,499 ▼ 33% vs 2022 (€ 109,680) Unfavourable step	€ 129,898 Profit after taxes 2024: € 129,898 ▲ 77% vs 2023 (€ 73,499) Favourable step	€ 138,135 Profit after taxes 2025: € 138,135 ▲ 6% vs 2024 (€ 129,898) Favourable step	▲ 6%
Equity	€ 162,476 Equity 2022: € 162,476 First fiscal year in the series	€ 235,974 Equity 2023: € 235,974 ▲ 45% vs 2022 (€ 162,476) Favourable step	€ 130,578 Equity 2024: € 130,578 ▼ 45% vs 2023 (€ 235,974) Unfavourable step	€ 148,713 Equity 2025: € 148,713 ▲ 14% vs 2024 (€ 130,578) Favourable step	▲ 14%
Total debts	€ 77,167 Total debts 2022: € 77,167 First fiscal year in the series	€ 57,423 Total debts 2023: € 57,423 ▼ 26% vs 2022 (€ 77,167) Favourable step	€ 49,014 Total debts 2024: € 49,014 ▼ 15% vs 2023 (€ 57,423) Favourable step	€ 36,178 Total debts 2025: € 36,178 ▼ 26% vs 2024 (€ 49,014) Favourable step	▼ 26%
Cash	€ 127,504 Cash 2022: € 127,504 First fiscal year in the series	€ 168,352 Cash 2023: € 168,352 ▲ 32% vs 2022 (€ 127,504) Favourable step	€ 59,662 Cash 2024: € 59,662 ▼ 65% vs 2023 (€ 168,352) Unfavourable step	€ 113,433 Cash 2025: € 113,433 ▲ 90% vs 2024 (€ 59,662) Favourable step	▲ 90%
Retained profit	€ 162,376 Retained profit 2022: € 162,376 First fiscal year in the series	€ 235,874 Retained profit 2023: € 235,874 ▲ 45% vs 2022 (€ 162,376) Favourable step	€ 130,478 Retained profit 2024: € 130,478 ▼ 45% vs 2023 (€ 235,874) Unfavourable step	€ 148,613 Retained profit 2025: € 148,613 ▲ 14% vs 2024 (€ 130,478) Favourable step	▲ 14%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 235,294 Dividend 2024: € 235,294 Unchanged (€ 0) Unchanged	€ 120,000 Dividend 2025: € 120,000 ▼ 49% vs 2024 (€ 235,294) Unchanged	▼ 49%
Bank debt	€ 45,054 Bank debt 2022: € 45,054 First fiscal year in the series	€ 32,622 Bank debt 2023: € 32,622 ▼ 28% vs 2022 (€ 45,054) Favourable step	€ 20,081 Bank debt 2024: € 20,081 ▼ 38% vs 2023 (€ 32,622) Favourable step	€ 7,430 Bank debt 2025: € 7,430 ▼ 63% vs 2024 (€ 20,081) Favourable step	▼ 63%
Balance sheet total	€ 239,643 Balance sheet total 2022: € 239,643 First fiscal year in the series	€ 293,397 Balance sheet total 2023: € 293,397 ▲ 22% vs 2022 (€ 239,643) Unchanged	€ 179,592 Balance sheet total 2024: € 179,592 ▼ 39% vs 2023 (€ 293,397) Unchanged	€ 184,891 Balance sheet total 2025: € 184,891 ▲ 3% vs 2024 (€ 179,592) Unchanged	▲ 3%

Key figures of DR. KRISTEL VANCHAZE, NEUROCHIRURGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. KRISTEL VANCHAZE, NEUROCHIRURGIE?

What happened at DR. KRISTEL VANCHAZE, NEUROCHIRURGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 9, 2026 New annual accounts for financial year 2025: profit of € 138,135 (▲ 6% vs 2024). Source: NBB ↗
Nov 10, 2020 New establishment in Lievegem. KBO
Nov 10, 2020 Start of the company according to the CBE. KBO

In short

From € 109,680 profit in 2022 to € 138,135 profit in 2025.

Paid € 131,394 in corporate taxes since 2022.

Best year ever: 2025, with € 138,135 profit.

Paid out € 355,294 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KRISTEL VANCHAZE, NEUROCHIRURGIE? We notify you, reason included.

Follow DR. KRISTEL VANCHAZE, NEUROCHIRURGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kristel Vanchaze

DR. KRISTEL VANCHAZE, NEUROCHIRURGIE

Behind DR. KRISTEL VANCHAZE, NEUROCHIRURGIE is Kristel Vanchaze.

See the full network in the app

Directors

According to the 2025 annual accounts

Kristel Vanchaze

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Langeboeken 3

9930 Lievegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0757.945.231
VAT number: BE 0757.945.231
Registered office: Langeboeken 3, 9930 Lievegem
Names & denominations: DR. KRISTEL VANCHAZE, NEUROCHIRURGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 November 2020
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗